Chemical Compound Review:
Noroxin 1-ethyl-6-fluoro-4-oxo-7- piperazin-1-yl...
Synonyms:
norfloxacin, AM-715, MK-366, AM-0715, MK-0366, ...
Tazi,
Moreau,
Hervé,
Dauvergne,
Cazals-Hatem,
Bert,
Poirel,
Rabiller,
Lebrec,
Albillos,
de la Hera,
González,
Moya,
Calleja,
Monserrat,
Ruiz-del-Arbol,
Alvarez-Mon,
Attar,
Flourié,
Rambaud,
Franchisseur,
Ruszniewski,
Bouhnik,
Tavío,
Vila,
Ruiz,
Ruiz,
Martín-Sánchez,
Jiménez de Anta,
- Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin. Crider, S.R., Colby, S.D., Miller, L.K., Harrison, W.O., Kerbs, S.B., Berg, S.W. N. Engl. J. Med. (1984)
- Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Soriano, G., Guarner, C., Teixidó, M., Such, J., Barrios, J., Enríquez, J., Vilardell, F. Gastroenterology (1991)
- Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Soriano, G., Guarner, C., Tomás, A., Villanueva, C., Torras, X., González, D., Sainz, S., Anguera, A., Cussó, X., Balanzó, J. Gastroenterology (1992)
- Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: role of Akt signaling. Tazi, K.A., Moreau, R., Hervé, P., Dauvergne, A., Cazals-Hatem, D., Bert, F., Poirel, O., Rabiller, A., Lebrec, D. Gastroenterology (2005)
- Treatment of adult gonococcal keratoconjunctivitis with oral norfloxacin. Kestelyn, P., Bogaerts, J., Stevens, A.M., Piot, P., Meheus, A. Am. J. Ophthalmol. (1989)
- An unusual hallucination with norfloxacin. Rataboli, P.V., D'Souza, R.S., Dhume, V.G. The Journal of the Association of Physicians of India. (1996)
- Fluoroquinolone-induced motor changes in the guinea-pig isolated ileum. Di Nucci, A., Candura, S.M., Tagliani, M., D'Agostino, G., Spelta, V., Fiori, E., Ricotti, P., Tonini, M. Pharmacol. Toxicol. (1998)
- Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. Wingard, J.R., Merz, W.G., Rinaldi, M.G., Johnson, T.R., Karp, J.E., Saral, R. N. Engl. J. Med. (1991)
- Topoisomerase IV, not gyrase, decatenates products of site-specific recombination in Escherichia coli. Zechiedrich, E.L., Khodursky, A.B., Cozzarelli, N.R. Genes Dev. (1997)
- Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. Boya, P., Andreau, K., Poncet, D., Zamzami, N., Perfettini, J.L., Metivier, D., Ojcius, D.M., Jäättelä, M., Kroemer, G. J. Exp. Med. (2003)
- Norfloxacin vs Ceftriaxone in the Prophylaxis of Infections in Patients With Advanced Cirrhosis and Hemorrhage. Fern??ndez, J., Del Arbol, L.R., G??mez, C., Durandez, R., Serradilla, R., Guarner, C., Planas, R., Arroyo, V., Navasa, M. Gastroenterology (2006)
- Norfloxacin: a new targeted fluoroquinolone antimicrobial agent. Wolfson, J.S., Hooper, D.C. Ann. Intern. Med. (1988)
- Effect of fluoroquinolone on the enhanced nitric oxide-induced peripheral vasodilation seen in cirrhosis. Chin-Dusting, J.P., Rasaratnam, B., Jennings, G.L., Dudley, F.J. Ann. Intern. Med. (1997)
- Antibiotics as intermicrobial signaling agents instead of weapons. Linares, J.F., Gustafsson, I., Baquero, F., Martinez, J.L. Proc. Natl. Acad. Sci. U.S.A. (2006)
- Selective bowel decontamination does not alter hepatic regeneration in rats. MacIntosh, E.L., Gauthier, T., Harding, G.K., Minuk, G.Y. Gastroenterology (1992)
- Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA. Shen, L.L., Pernet, A.G. Proc. Natl. Acad. Sci. U.S.A. (1985)
- Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Karp, J.E., Merz, W.G., Hendricksen, C., Laughon, B., Redden, T., Bamberger, B.J., Bartlett, J.G., Saral, R., Burke, P.J. Ann. Intern. Med. (1987)
- Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis. Runyon, B.A., Borzio, M., Young, S., Squier, S.U., Guarner, C., Runyon, M.A. Hepatology (1995)
- Effect of inoculum size on in vitro activity of norfloxacin against fecal anaerobic bacteria. Rationale for selective decontamination of the digestive tract. Goldstein, E.J., Citron, D.M., Corrado, M.L. Am. J. Med. (1987)
- Gemfibrozil enhances the listeriacidal effects of fluoroquinolone antibiotics in J774 macrophages. Rudin, D.E., Gao, P.X., Cao, C.X., Neu, H.C., Silverstein, S.C. J. Exp. Med. (1992)
- Randomised trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin. Barrioz, T., Ingrand, P., Besson, I., de Ledinghen, V., Silvain, C., Beauchant, M. Lancet (1994)
- Selective intestinal decontamination increases serum and ascitic fluid C3 levels in cirrhosis. Such, J., Guarner, C., Soriano, G., Teixidó, M., Barrios, J., Tena, F., Méndez, C., Enríquez, J., Rodríguez, J.L., Vilardell, F. Hepatology (1990)
- Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Albillos, A., de la Hera, A., González, M., Moya, J.L., Calleja, J.L., Monserrat, J., Ruiz-del-Arbol, L., Alvarez-Mon, M. Hepatology (2003)
- Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones. Blum, R.A. Am. J. Med. (1992)
- The mechanism of inhibition of topoisomerase IV by quinolone antibacterials. Khodursky, A.B., Cozzarelli, N.R. J. Biol. Chem. (1998)
- Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Rabiller, A., Nunes, H., Lebrec, D., Tazi, K.A., Wartski, M., Dulmet, E., Libert, J.M., Mougeot, C., Moreau, R., Mazmanian, M., Humbert, M., Hervé, P. Am. J. Respir. Crit. Care Med. (2002)
- Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV. Breines, D.M., Ouabdesselam, S., Ng, E.Y., Tankovic, J., Shah, S., Soussy, C.J., Hooper, D.C. Antimicrob. Agents Chemother. (1997)
- NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Morita, Y., Kodama, K., Shiota, S., Mine, T., Kataoka, A., Mizushima, T., Tsuchiya, T. Antimicrob. Agents Chemother. (1998)
- Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates. Tavío, M.M., Vila, J., Ruiz, J., Ruiz, J., Martín-Sánchez, A.M., Jiménez de Anta, M.T. J. Antimicrob. Chemother. (1999)
- Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Attar, A., Flourié, B., Rambaud, J.C., Franchisseur, C., Ruszniewski, P., Bouhnik, Y. Gastroenterology (1999)
- Quinolone binding to DNA is mediated by magnesium ions. Palù, G., Valisena, S., Ciarrocchi, G., Gatto, B., Palumbo, M. Proc. Natl. Acad. Sci. U.S.A. (1992)